Originally, sprouting angiogenesis was thought to be the sole form of angiogenesis; however, it is now clear that alternative neovascularisation pathways exist in GBM, rendering traditional single-target VEGF inhibitors ineffective. This evidence concerns the gene VEGFA and glioblastoma.